Vaxart Inc (NASDAQ:VXRT)’s traded shares stood at 1.34 million during the last session, with the company’s beta value hitting 0.81. At the close of trading, the stock’s price was $0.74, to imply an increase of 1.46% or $0.01 in intraday trading. The VXRT share’s 52-week high remains $1.54, putting it -108.11% down since that peak but still an impressive 29.73% since price per share fell to its 52-week low of $0.52. The company has a valuation of $168.72M, with an average of 3.16 million shares in intraday trading volume over the past 10 days and average of 1.77 million shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Vaxart Inc (VXRT), translating to a mean rating of 1.00. Of 2 analyst(s) looking at the stock, 0 analyst(s) give VXRT a Sell rating. 0 of those analysts rate the stock as Overweight while 1 advise Hold as 1 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.11.
Vaxart Inc (NASDAQ:VXRT) trade information
After registering a 1.46% upside in the last session, Vaxart Inc (VXRT) has traded red over the past five days. The 5-day price performance for the stock is -15.37%, and 24.34% over 30 days. With these gigs, the year-to-date price performance is 12.02%. Short interest in Vaxart Inc (NASDAQ:VXRT) saw shorts transact 11.27 million shares and set a 11.71 days time to cover.
The extremes give us $2 and $2 for target low and target high price respectively. As such, VXRT has been trading -170.27% off suggested target high and -170.27% from its likely low.
Vaxart Inc (VXRT) estimates and forecasts
Looking at statistics comparing Vaxart Inc share performance against respective industry, we note that the company has outperformed competitors. Vaxart Inc (VXRT) shares are 1.56% up over the last 6 months, with its year-to-date growth rate higher than industry average at 31.58% against 16.30%. The rating firms project that company’s revenue will grow 364.83% compared to the previous financial year.
Revenue forecast for the current quarter as set by 4 analysts is 15.68M. Meanwhile, for the current quarter, a total of 3 analyst(s) estimate revenue growth to 8.33M.Earnings reports from the last fiscal year show that sales brought in 3.25M and 2.18M respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to rise 383.05% before jumping 282.09% in the following quarter.
VXRT Dividends
Vaxart Inc has its next earnings report out in February. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Vaxart Inc (NASDAQ:VXRT)’s Major holders
Vaxart Inc insiders hold 0.87% of total outstanding shares, with institutional holders owning 17.80% of the shares at 17.96% float percentage. In total, 17.80% institutions holds shares in the company, led by HERITAGE WEALTH ADVISORS. As of 2024-06-30, the company held over 21780.0 shares (or 9.5756% of shares), all amounting to roughly $14534.0.
The next major institution holding the largest number of shares is SIO CAPITAL MANAGEMENT, LLC with 14.76 million shares, or about 8.7465% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $9.85 million.
We also have Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the Vaxart Inc (VXRT) shares. Going by data provided on Sep 30, 2024 , Vanguard Total Stock Market Index Fund holds roughly 7.16 shares. This is just over 3.15% of the total shares, with a market valuation of $5.31 million. Data from the same date shows that the other fund manager holds a little less at 2.52, or 1.11% of the shares, all valued at about 1.87 million.
